Recombinant Human Epidermal Growth Factor GMP (rHuEGF)

英文全名

Recombinant Human Epidermal Growth Factor GMP (rHuEGF)

英文别名

Urogastrone

蛋白结构

Squence of Recombinant Human Epidermal Growth Factor GMP

氨基酸序列

NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR

Accession

P01133

Gene ID

1950

产品英文概述

Epidermal Growth Factor (EGF) was originally discovered in crude preparations of nerve growth factor prepared from mouse submaxillary glands as an activity that induced early eyelid opening, incisor eruption, hair growth inhibition, and stunting of growth when injected into newborn mice. Human EGF was isolated from urine based on its inhibitory effect on gastric secretion and named urogastrone, accordingly. EGF is prototypic of a family of growth factors that are derived from membrane-anchored precursors. All members of this family are characterized by the presence of at least one EGF structural unit (defined by the presence of a conserved 6 cysteine motif that forms three disulfide bonds) in their extracellular domain. EGF is initially synthesized as a 130 kDa precursor transmembrane protein containing 9 EGF units. The mature soluble EGF sequence corresponds to the EGF unit located proximal to the transmembrane domain. The membrane EGF precursor is capable of binding to the EGF receptor and was reported to be biologically active. Mature human EGF shares 70 % a.a. sequence identity with mature mouse and rat EGF.

来源

Escherichia coli.

分子量

Approximately 6.2 kDa, a single non-glycosylated polypeptide chain containing 53 amino acids.

生物活性

Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine Balb/c 3T3 cells is less than 0.1 ng/ml, corresponding to a specific activity of > 1.0 × 107 IU/mg.

外观

Sterile filtered white lyophilized (freeze-dried) powder.

配方

Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4.

内毒素

Less than 0.01 EU/ug of rHuEGF GMP as determined by LAL method.

溶解说明

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

储存条件

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.A minimum of 12 months when stored at ≤ -20 °C as supplied. Refer to lot specific COA for the Use by Date.1 month, 2 to 8 °C under sterile conditions after reconstitution.3 months, -20 to -70 °C under sterile conditions after reconstitution.

参考资料

1. Chevalier RL, Goyal S, Thornhill BA. 1999. J Urol, 162: 1532-6.2. Gehm BD, McAndrews JM, Jordan VC, et al. 2000. Mol Cell Endocrinol, 159: 53-62.3. Yang H, Sun X, Wang Z, et al. 2003. J Membr Biol, 194: 47-58.4. Cohen S. 2008. J Biol Chem, 283: 33793-7.

纯度

> 98 % by SDS-PAGE and HPLC analyses.
SDS-PAGE of Recombinant Human Epidermal Growth Factor GMP

包装规格

5ug/100ug

安全数据表下载 (SDS)

点击下载

技术参数表下载 (TDS)

点击下载

品牌链接

Recombinant Human Epidermal Growth Factor GMP是ChemWhat品牌授权产品并通过沃尔森销售,下面是ChemWhat上的该产品链接Recombinant Human Epidermal Growth Factor GMP (rHuEGF)